| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-06 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-06 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.21 | 8e-06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-05 |